ID   LAPC-9
AC   CVCL_4746
SY   LAPC9; Los Angeles Prostate Cancer-9
DR   EFO; EFO_0005393
DR   Cosmic; 2580123
DR   Wikidata; Q54901928
RX   Patent=US6365797;
RX   PubMed=10519419;
RX   PubMed=10861745;
RX   PubMed=15643173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1442.
CC   Derived from site: Metastatic; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
RX   Patent=US6365797;
RA   Sawyers C.L., Klein K.A., Witte O.N., Reiter R.E.;
RT   "Mice models of human prostate cancer progression.";
RL   Patent number US6365797, 02-Apr-2002.
//
RX   PubMed=10519419;
RA   Craft N., Chhor C., Tran C., Belldegrun A.S., deKernion J.B., Witte O.N.,
RA   Said J.W., Reiter R.E., Sawyers C.L.;
RT   "Evidence for clonal outgrowth of androgen-independent prostate cancer
RT   cells from androgen-dependent tumors through a two-step process.";
RL   Cancer Res. 59:5030-5036(1999).
//
RX   PubMed=10861745; DOI=10.1002/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I;
RA   van Weerden W.M., Romijn J.C.;
RT   "Use of nude mouse xenograft models in prostate cancer research.";
RL   Prostate 43:263-271(2000).
//
RX   PubMed=15643173; DOI=10.1097/01.ju.0000149989.01263.dc;
RA   Sobel R.E., Sadar M.D.;
RT   "Cell lines used in prostate cancer research: a compendium of old and
RT   new lines -- part 2.";
RL   J. Urol. 173:360-372(2005).
//